Abstract: This application relates to an aqueous formulation of fenbendazole which is stable and efficacious, does not agglomerate upon standing and wherein the fenbendazole remains in suspension after standing for twenty-four hours.
Abstract: This application relates to a novel thixotropic formulation of a compound which suppresses estrus in animals, which formulation allows for convenient, accurate dosing of the animal when treated with the compound.